We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-2.95%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$481B
AUM Growth
-$11.2B
Cap. Flow
+$6.33B
Cap. Flow %
1.32%
Top 10 Hldgs %
27.75%
Holding
13,532
New
1,585
Increased
5,250
Reduced
4,926
Closed
1,614

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.26B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12B
3
AAPL icon
Apple
AAPL
+$986M
4
AMZN icon
Amazon
AMZN
+$676M
5
KVUE icon
Kenvue
KVUE
+$501M

Sector Composition

Rank Sector Weight
1 Technology 2.36%
2 Consumer Discretionary 1.65%
3 Financials 1.08%
4 Healthcare 0.89%
5 Communication Services 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAGN
11526
PUT
Magnera Corp
MAGN
$454M
$21.2K ﹤0.01%
+815
New +$27.1K
VJET
11527
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$21.2K ﹤0.01%
+20,150
New +$28.4K
LILM
11528
CALL
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$20.9K ﹤0.01%
29,500
-67,800
-70% -$79.2K
NEWP
11529
PUT
New Pacific Metals
NEWP
$1.31B
$20.9K ﹤0.01%
11,800
-25,700
-69% -$60.2K
ENZ
11530
CALL
DELISTED
Enzo Biochem, Inc.
ENZ
$20.9K ﹤0.01%
+14,900
New +$22.5K
OSS icon
11531
CALL
One Stop Systems
OSS
$277M
$20.7K ﹤0.01%
11,200
-3,800
-25% -$8.84K
XERS icon
11532
PUT
Xeris Biopharma Holdings
XERS
$1.59B
$20.6K ﹤0.01%
11,100
-7,000
-39% -$16K
TBIO
11533
PUT
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$20.6K ﹤0.01%
+1,100
New +$26.8K
STKH
11534
Steakholder Foods
STKH
$3.54M
$20.5K ﹤0.01%
20
+3
+18% +$3.71K
OGI
11535
CALL
Organigram Holdings
OGI
$179M
$20.5K ﹤0.01%
+15,500
New +$23.4K
GYRE icon
11536
Gyre Therapeutics
GYRE
$708M
$20.4K ﹤0.01%
2,823
-847
-23% -$5.67K
CURI icon
11537
CALL
CuriosityStream
CURI
$161M
$20.3K ﹤0.01%
28,600
ABSI icon
11538
CALL
Absci
ABSI
$1.65B
$20.2K ﹤0.01%
15,300
-153,600
-91% -$269K
RJET
11539
Republic Airways Holdings
RJET
$897M
$20K ﹤0.01%
1,555
-3,334
-68% -$86.5K
VZLA
11540
Vizsla Silver
VZLA
$1.42B
$20K ﹤0.01%
19,319
+7,839
+68% +$8.57K
SPRU icon
11541
Spruce Power Holding Corp
SPRU
$41.2M
$19.9K ﹤0.01%
3,659
-7,287
-67% -$48.4K
GRNQ icon
11542
Greenpro Capital
GRNQ
$21.9M
$19.9K ﹤0.01%
+1,930
New +$26.1K
YGMZ
11543
DELISTED
MingZhu Logistics Holdings
YGMZ
$19.8K ﹤0.01%
336
+48
+17% +$4.06K
KITTW icon
11544
Nauticus Robotics Warrant
KITTW
$179K
$19.7K ﹤0.01%
89,426
-8,964
-9% -$1.93K
XFOR icon
11545
PUT
X4 Pharmaceuticals
XFOR
$412M
$19.6K ﹤0.01%
600
-5,653
-90% -$247K
IGC icon
11546
IGC Pharma
IGC
$31.5M
$19.6K ﹤0.01%
54,551
-20,607
-27% -$7.37K
PAVM icon
11547
CALL
PAVmed
PAVM
$42.2M
$19.4K ﹤0.01%
149
-17
-10% -$2.64K
NEON icon
11548
PUT
Neonode
NEON
$15.3M
$19.4K ﹤0.01%
12,100
-2,500
-17% -$7.3K
PRPL icon
11549
PUT
Purple Innovation
PRPL
$20.7M
$19.3K ﹤0.01%
452
-368
-45% -$22.9K
SEEL
11550
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$19.3K ﹤0.01%
27
+13
+93% +$55.7K

Similar funds

Jeff Yass's Q3 2023 Portfolio in Review

As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
  • Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
  • Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
  • Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
  • Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
  • Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.